BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7646466)

  • 1. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.
    Lund LR; Ellis V; Rønne E; Pyke C; Danø K
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):345-52. PubMed ID: 7646466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
    Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
    Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase receptor mRNA stability involves tyrosine phosphorylation in lung epithelial cells.
    Shetty S; Idell S
    Am J Respir Cell Mol Biol; 2004 Jan; 30(1):69-75. PubMed ID: 12816732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of urokinase-type plasminogen activator receptor by cyclic AMP in PL-21 human myeloid leukemia cells: comparison with the regulation by phorbol myristate acetate.
    Niiya K; Ozawa T; Tsuzawa T; Ueshima S; Matsuo O; Sakuragawa N
    Thromb Haemost; 1998 Mar; 79(3):574-8. PubMed ID: 9531044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis.
    Shetty S; Kumar A; Johnson A; Pueblitz S; Idell S
    Am J Physiol; 1995 Jun; 268(6 Pt 1):L972-82. PubMed ID: 7611439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.
    Montuori N; Mattiello A; Mancini A; Santoli M; Taglialatela P; Caputi M; Rossi G; Ragno P
    FEBS Lett; 2001 Nov; 508(3):379-84. PubMed ID: 11728456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.
    Khatib AM; Nip J; Fallavollita L; Lehmann M; Jensen G; Brodt P
    Int J Cancer; 2001 Feb; 91(3):300-8. PubMed ID: 11169951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor.
    Montuori N; Salzano S; Rossi G; Ragno P
    FEBS Lett; 2000 Jul; 476(3):166-70. PubMed ID: 10913606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
    Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
    Shetty S; Kumar A; Idell S
    Mol Cell Biol; 1997 Mar; 17(3):1075-83. PubMed ID: 9032234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.
    Shetty S; Idell S
    Mol Cell Biochem; 1999 Sep; 199(1-2):189-200. PubMed ID: 10544967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta induces urokinase receptor expression in cultured retinal pigment epithelial cells.
    Sirén V; Myöhänen H; Vaheri A; Immonen I
    Ophthalmic Res; 1999; 31(3):184-91. PubMed ID: 10224501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
    Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
    Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.
    Yebra M; Parry GC; Strömblad S; Mackman N; Rosenberg S; Mueller BM; Cheresh DA
    J Biol Chem; 1996 Nov; 271(46):29393-9. PubMed ID: 8910604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
    Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS
    Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.
    Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G
    Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
    Mori T; Abe T; Wakabayashi Y; Hikawa T; Matsuo K; Yamada Y; Kuwano M; Hori S
    J Neurooncol; 2000; 46(2):115-23. PubMed ID: 10894364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
    Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
    J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.